Table 3 Differences between patients with thalamic haemorrhage and patients with internal capsule-basal ganglia haemorrhage
Data | Thalamic haemorrhage | Internal capsule-basal ganglia haemorrhage | P value |
|---|---|---|---|
Total patients | 47 | 77 | |
Sex, male | 27 (57.4) | 50 (64.9) | 0.259 |
Age, years, mean (SD) | 71.6 (10.9) | 72.2 (12.2) | 0.661 |
Vascular risk factors | |||
Hypertension | 29 (61.7) | 57 (74) | 0.107 |
Diabetes mellitus | 8 (17) | 9 (11.7) | 0.282 |
Dyslipemia | 7 (14.9) | 10 (13) | 0.481 |
Atrial fibrillation | 5 (10.6) | 11 (14.3) | 0.384 |
Ischaemic heart disease | 3 (6.4) | 5 (6.5) | 0.646 |
Cigarette smoking (> 20/day) | 3 (6.4) | 8 (10.4) | 0.339 |
Chronic liver disease | 5 (10.6) | 0 | 0.007 |
Clinical findings | |||
Sudden onset (min) | 35 (74.5) | 48 (52.3) | 0.115 |
Limb weakness | 37 (78.7) | 67 (87) | 0.167 |
Sensory symptoms | 33 (70.2) | 38 (49.4) | 0.018 |
Altered consciousness | 15 (31.9) | 23 (29.9) | 0.482 |
Headache | 14 (29.8) | 18 (23.4) | 0.279 |
Nausea, vomiting | 13 (27.7) | 10 (13) | 0.037 |
Speech disturbances (dysarthria, aphasia) | 10 (21.3) | 34 (44.2) | 0.008 |
Ataxia | 4 (8.5) | 0 | 0.019 |
Lacunar syndrome | 4 (8.5) | 18 (23.4) | 0.036 |
Ventricular involvement | 20 (42.6) | 12 (15.6) | 0.001 |
Outcome | |||
In-hospital mortality | 9 (19.1) | 13 (16.9) | 0.464 |
Respiratory complications | 8 (17) | 8 (10.4) | 0.212 |
Urinary complications | 8 (17) | 7 (9.1) | 0.152 |
Infectious complications | 16 (34) | 17 (22.1) | 0.106 |
Symptom-free at discharge | 1 (2.1) | 6 (7.8) | 0.180 |